Health
‘Stretched’ Vic hospital pleads for staff – Shepparton News
An Australian-first trial aims to “once and for all” settle the science surrounding an antimalarial drug touted by US President Donald Trump as protection from COVID-19.The “COVID shield” study, led by Melbourne’s Walter and Eliza Hall Institute, has recruited more than 100 healthcare workers to test the efficacy of hydroxychloroquine.Study co-lead Marc Pellegrini said half of study participants would be given the drug and the rest a placebo tablet over a four-month span to determine its effecti…
Continue Reading
